指南与共识焦虑、强迫与应激相关障碍心境障碍物质与行为成瘾

WHO mhGAP指南更新:精神、神经与物质使用障碍的新版推荐

The WHO Mental Health Gap Action Programme for mental, neurological, and substance use conditions: the new and updated guideline recommendations.
指南 / 共识 · Lancet Psychiatry · 2023-11-16

WHO mhGAP指南更新基于15年缩小治疗差距的投入,由指南制定组与指导组利用定量和定性证据及系统综述完成。2015版90条推荐获验证保留,新增30条修订推荐和18条新推荐,包括焦虑新模块,强调心理干预与数字化干预。

要点

  • 2015版90条推荐经验证保留,新增30条修订和18条新推荐。
  • 新增焦虑模块,心理干预被强调为治疗手段。
  • 数字化干预出现在多个模块,精神药物推荐也有更新。

核心结论

  • 更新版mhGAP指南为低收入和中等收入国家的非专科卫生工作者提供高质量、及时、透明且基于证据的指导。

研究设计与样本

  • 由指南制定组和指导组在主题专家支持下制定,使用定量和定性证据及对mhGAP使用的系统综述。

主要发现

  • 2015版指南更新中的90条推荐被验证并认可按当前格式使用。
  • 新增30条修订推荐和18条新推荐,其中包括一个关于焦虑的新模块。
  • 心理干预被强调作为治疗手段,数字化实施的干预出现在许多模块中。
  • 研究空白包括需要来自低资源环境的证据以及关于有MNS状况亲身经历者观点的证据。

关键数值与推荐

  • 2015版指南更新中的90条推荐被验证并认可按当前格式使用。
  • 新增30条修订推荐和18条新推荐。
  • 新增一个关于焦虑的模块。

临床怎么用

  • 支持低收入和中等收入国家的非专科卫生工作者为精神、神经和物质使用障碍患者提供照护。

局限性

  • 研究空白包括需要来自低资源环境的证据以及关于有MNS状况亲身经历者观点的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The WHO Mental Health Gap Action Programme (mhGAP) guideline update reflects 15 years of investment in reducing the treatment gap and scaling up care for people with mental, neurological, and substance use (MNS) conditions. It was produced by a guideline development group and steering group, with support from topic experts, using quantitative and qualitative evidence and a systematic review of use of mhGAP. 90 recommendations from the 2015 guideline update were validated and endorsed for use in their current format. These are joined by 30 revised recommendations and 18 new recommendations, including a new module on anxiety. Psychological interventions are emphasised as treatments and digitally delivered interventions feature across many modules, as well as updated recommendations for psychotropic medicines. Research gaps identified include the need for evidence from low-resource settings and on the views of people with lived experience of MNS conditions. The revised recommendations ensure that mhGAP continues to offer high-quality, timely, transparent, and evidence-based guidance to support non-specialist health workers in low-income and middle-income countries in providing care to individuals with MNS conditions.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Brohan E, Chowdhary N, Dua T, et al. The WHO Mental Health Gap Action Programme for mental, neurological, and substance use conditions: the new and updated guideline recommendations. Lancet Psychiatry. 2023. PMID: 37980915. doi:10.1016/S2215-0366(23)00370-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。